Danaher Corporation $DHR Shares Sold by Amundi

Amundi reduced its holdings in Danaher Corporation (NYSE:DHR) by 3.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,943,272 shares of the conglomerate’s stock after selling 110,339 shares during the period. Amundi owned about 0.41% of Danaher worth $596,013,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. SCS Capital Management LLC grew its stake in Danaher by 15.4% in the 2nd quarter. SCS Capital Management LLC now owns 3,996 shares of the conglomerate’s stock valued at $790,000 after acquiring an additional 532 shares during the period. Annandale Capital LLC acquired a new position in Danaher during the second quarter worth $1,007,000. Great Diamond Partners LLC acquired a new position in Danaher during the second quarter worth $618,000. Baird Financial Group Inc. grew its position in shares of Danaher by 28.1% in the second quarter. Baird Financial Group Inc. now owns 1,847,491 shares of the conglomerate’s stock valued at $364,953,000 after purchasing an additional 405,785 shares during the period. Finally, First Trust Advisors LP increased its stake in shares of Danaher by 34.5% during the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock worth $10,947,000 after purchasing an additional 14,217 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

DHR has been the subject of several research analyst reports. Rothschild Redb downgraded shares of Danaher from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 8th. Bank of America cut their price objective on Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research note on Monday, September 22nd. Deutsche Bank Aktiengesellschaft increased their target price on Danaher from $235.00 to $250.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Morgan Stanley started coverage on Danaher in a research note on Monday. They issued an “overweight” rating and a $270.00 price target on the stock. Finally, Cowen reiterated a “buy” rating on shares of Danaher in a research report on Wednesday, October 22nd. Twenty investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average target price of $245.75.

Insider Activity at Danaher

In other news, Director Teri List sold 3,298 shares of the stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the completion of the sale, the director owned 20,762 shares of the company’s stock, valued at $4,702,593. This represents a 13.71% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the sale, the senior vice president directly owned 14,553 shares in the company, valued at approximately $3,190,454.19. The trade was a 59.94% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 30,248 shares of company stock valued at $6,609,663. 11.10% of the stock is owned by company insiders.

Danaher Trading Down 0.6%

Shares of Danaher stock opened at $227.13 on Friday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. The stock’s 50 day simple moving average is $215.40 and its 200-day simple moving average is $204.10. The stock has a market cap of $160.43 billion, a P/E ratio of 46.83, a P/E/G ratio of 4.43 and a beta of 0.89. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $258.23.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. The firm had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.71 earnings per share. Analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were given a dividend of $0.32 per share. The ex-dividend date of this dividend was Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s payout ratio is presently 26.39%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.